Gilead is committed to ensuring that a drug's price is never a barrier to access. We support a number of programs that help ensure patients who need our therapies have access to them.

Patient Access in the United States

Gilead supports a number of programs for eligible patients in the United States who do not have insurance, are underinsured or who otherwise need financial assistance. These programs include U.S. Advancing Access®, Atripla® Patient Assistance Program, Gilead™Solutions, the Cayston® Access Program and Ranexa Connect™.

Patient Access in the Developing World

Gilead recognizes the tremendous need for Access in the Developing World. International Access Operations works to provide our HIV drugs at reduced prices in resource-limited countries where the AIDS epidemic has hit hardest, as well as treatment for leishmaniasis.